Effects of lactoferrin on elicitation of the antigenspecific cellular and humoral cutaneous response in mice

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 66, Issue , 2012, Pages 16-22

  Zimecki, Michał ^a   Artym, Jolanta ^a   Kociȩba, Maja ^a   Kruzel, Marian ^b  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Contact dermatitis; Lactoferrin; Mice; Oxazolone; Toluene diisocyanate

Indexed keywords

EID: 84867942037     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: 10.5604/17322693.975145     Document Type: Review

References (36)

1. Actor J. K., Hwang S. A., Kruzel M. L.: Lactoferrin as a natural immune modulator. Curr. Pharm. Des., 2009;15:1956-1973
2. Actor J. K., Hwang S. A., Olsen M., Zimecki M., Hunter R. Jr., Kruzel M. L.: Lactoferrin immunomodulation of DTH response in mice. Int. Immunopharmacol., 2002;2:475-486
3. Artym J., Zimecki M., Kruzel M. L.: Effect of lactoferrin on the methotrexate-induced suppression of the cellular and humoral immune response in mice. Anticancer Res., 2004;24:3831-3836
4. Artym J., Zimecki M., Kruzel M. L.: Reconstitution of the cellular immune response by lactoferrin in cyclophosphamide-treated mice is correlated with renewal of T cell compartment. Immunobiology, 2003;207:197-205
5. Artym J., Zimecki M., Paprocka M., Kruzel M. L.: Orally administered lactoferrin restores humoral immune response in immunocompromised mice. Immunol. Lett., 2003;89:9-15
6. Basketter D. A., Wilhelm K. P.: Studies on non-immune immediate contact reactions in an unselected population. Contact Dermatitis, 1996;35:237-240
7. Das R., Moss J. E., Robinson E., Roberts S., Levy R., Mizue Y., Leng L., McDonald C., Tigelaar R. E., Herrick C. A., Bucala R.: Role of macrophage migration inhibitory factor in the Th2 immune response to epicutaneous sensitization. J. Clin. Immunol., 2011;31:666-680
8. Dearman R. J., Kimber I.: Role of CD4+ T helper 2-type cells in cutaneous inflammatory responses induced by fluorescein isothiocyanate. Immunology, 2000;101:442-451
9. Draelos Z. D.: Use of topical corticosteroids and topical calcineurin inhibitors for the treatment of atopic dermatitis in thin and sensitive skin areas. Curr. Med. Res. Opin., 2008;24:985-994
10. Elenkov I. J.: Glucocorticoids and the Th1/Th2 balance. Ann. N Y Acad. Sci., 2004;1024:138-146
11. Fischer R., Debbabi H., Dubarry M., Boyaka P., Tomé D.: Regulation of physiological and pathological Th1 and Th2 responses by lactoferrin. Biochem. Cell Biol., 2006;84:303-311
12. Gober M. D., Gaspari A. A.: Allergic contact dermatitis. Curr. Dir. Autoimmun., 2008;10:1-26
13. Griffiths C. E., Cumberbatch M., Tucker S. C., Dearman R. J., Andrew S., Headon D. R., Kimber I.: Exogenous topical lactoferrin inhibits allergen-induced Langerhans cell migration and cutaneous inflammation in humans. Br. J. Dermatol., 2001;144:715-725
14. Guillén C., McInnes I. B., Vaughan D. M., Kommajosyula S., Van Berkel P. H., Leung B. P., Aguila A., Brock J. H.: Enhanced Th1 response to Staphylococcus aureus infection in human lactoferrin-transgenic mice. J. Immunol., 2002;168:3950-3957
15. Hansen M. B., Nielsen S. E., Berg K.: Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods, 1989;119:203-210
16. Herrick C. A., Xu L., McKenzie A. N., Tigelaar R. E., Bottomly K.: IL-13 is necessary, not simply sufficient, for epicutaneously induced Th2 responses to soluble protein antigen. J. Immunol., 2003;170:2488-2495
17. Hsu C. J., Wang L. F.: Emerging treatment of atopic dermatitis. Clin. Rev. Allergy Immunol., 2007;33:199-203
18. Hwang S. A., Kruzel M. L., Actor J. K.: Influence of bovine lactoferrin on expression of presentation molecules on BCG-infected bone marrow derived macrophages. Biochimie, 2009;91:76-85
19. Katoh N.: Future perspectives in the treatment of atopic dermatitis. J. Dermatol., 2009;36:367-376
20. Kociȩba M., Zimecki M., Kruzel M., Actor J.: The adjuvant activity of lactoferrin in the generation of DTH to ovalbumin can be inhibited by bovine serum albumin bearing alpha-D-mannopyranosyl residues. Cell. Mol. Biol. Lett., 2002;7:1131-1136
21. Legrand D., Mazurier J.: A critical review of the roles of host lactoferrin in immunity. Biometals, 2010;23:365-376
22. Legrand D., Pierce A., Elass E., Carpentier M., Mariller C., Mazurier J.: Lactoferrin structure and functions. Adv. Exp. Med. Biol., 2008;606:163-194
23. Noonan F. P., Halliday W. J.: Studies of contact hypersensitivity and tolerance in vivo and in vitro. I. Basic characteristics of the reactions and confirmation of an immune response in tolerant mice. Int. Arch. Allergy Appl. Immunol., 1978;56:523-532
24. Scheper R. J., van Dinther-Janssen A. C., Polak L.: Specific accumulation of hapten-reactive T cells in contact sensitivity reaction sites. J. Immunol., 1985;134:1333-1336
25. van Dinther-Janssen A. C., van Maarsseveen A. C., de Groot J., Scheper R. J.: Comparative migration of T-and B-lymphocyte subpopulations into skin inflammatory sites. Immunology, 1983;48:519-527
26. Van Buskirk A. M., Adams P. W., Orosz C. G.: Nonradioactive alternative to clinical mixed lymphocyte reaction. Hum. Immunol., 1995;43:38-44
27. Yamamoto S., Sugahara S., Ikeda K., Shimizu Y.: Pharmacological profile of a novel phosphodiesterase 7A and -4 dual inhibitor, YM-393059, on acute and chronic inflammation models. Eur. J. Pharmacol., 2006;550:166-172
28. Zhang D., Kishihara K., Wang B., Mizobe K., Kubo C., Nomoto K.: Restraint stress-induced immunosuppression by inhibiting leukocyte migration and Th1 cytokine expression during the intraperitoneal infection of Listeria monocytogenes. J. Neuroimmunol., 1998;92:139-151
29. Zimecki M., Artym J., Chodaczek G., Kociȩba M., Kruzel M.: Effects of lactoferrin on the immune response modified by the immobilization stress. Pharmacol. Rep., 2005;57:811-817
30. Zimecki M., Artym J., Kociȩba M.: Endogenous steroids are responsible for lactoferrin-induced myelopoiesis in mice. Pharmacol. Rep., 2009;61:705-710
31. Zimecki M., Kruzel M. L.: Systemic or local co-administration of lactoferrin with sensitizing dose of antigen enhances delayed type hypersensitivity in mice. Immunol. Lett., 2000;74:183-188
32. Zimecki M., Machnicki M.: Lactoferrin inhibits the effector phase of the delayed type hypersensitivity to sheep erythrocytes and inflammatory reactions to M. bovis (BCG). Arch. Immunol. Ther. Exp., 1994;42:171-177
33. Zimecki M., Mazurier J., Machnicki M., Wieczorek Z., Montreuil J., Spik G.: Immunostimulatory activity of lactotransferrin and maturation of CD4-CD8-murine thymocytes. Immunol. Lett., 1991;30:119-123
34. Zimecki M., Mazurier J., Spik G., Kapp J. A.: Human lactoferrin induces phenotypic and functional changes in murine splenic B cells. Immunology, 1995;86:122-127
35. Zimecki M., Mazurier J., Spik G., Kapp J. A.: Lactoferrin inhibits proliferative response and cytokine production of TH1 but not TH2 cell lines. Arch. Immunol. Ther. Exp., 1996;44:51-56
36. Zimecki M., Miȩdzybrodzki R., Mazurier J., Spik G.: Regulatory effects of lactoferrin and lipopolysaccharide on LFA-1 expression on human peripheral blood mononuclear cells. Arch. Immunol. Ther. Exp., 1999;47:257-264